Cargando…
Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease
Cognitive impairment in patients with Parkinson's disease is a major challenge since it has been established that 25 to 40% of patients will develop cognitive impairment early in the disease. Furthermore, it has been reported that up to 80% of Parkinsonian patients will eventually develop demen...
Autores principales: | Hanganu, Alexandru, Monchi, Oury |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848447/ https://www.ncbi.nlm.nih.gov/pubmed/27190672 http://dx.doi.org/10.1155/2016/3217960 |
Ejemplares similares
-
Neuroimaging studies of striatum in cognition part II: Parkinson's disease
por: Hanganu, Alexandru, et al.
Publicado: (2015) -
Neuroimaging studies of the striatum in cognition Part I: healthy individuals
por: Provost, Jean-Sebastien, et al.
Publicado: (2015) -
Machine learning-based prediction of longitudinal cognitive decline in early Parkinson’s disease using multimodal features
por: Almgren, Hannes, et al.
Publicado: (2023) -
Patterns of Longitudinal Neural Activity Linked to Different Cognitive Profiles in Parkinson's Disease
por: Nagano-Saito, Atsuko, et al.
Publicado: (2016) -
Differential Effects of Dopaminergic Therapies on Dorsal and Ventral Striatum in Parkinson's Disease: Implications for Cognitive Function
por: MacDonald, Penny A., et al.
Publicado: (2011)